172 related articles for article (PubMed ID: 2878349)
41. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.
Khoo DH; Eng PH; Ho SC; Tai ES; Morgenthaler NG; Seah LL; Fong KS; Chee SP; Choo CT; Aw SE
Thyroid; 2000 Dec; 10(12):1093-100. PubMed ID: 11201855
[TBL] [Abstract][Full Text] [Related]
42. Clinical significance of classification of Graves' disease according to the characteristics of TSH receptor antibodies.
Kim WB; Chung HK; Park YJ; Park DJ; Lee HK; Cho BY
Korean J Intern Med; 2001 Sep; 16(3):187-200. PubMed ID: 11769578
[TBL] [Abstract][Full Text] [Related]
43. Radioreceptor assay of anti-TSH receptor antibody activity: comparison of assays using unextracted serum and immunoglobulin fractions, and standardization of expression of activities.
Tamaki H; Amino N; Watanabe Y; Aozasa M; Hayashi H; Tachi J; Miyai K
J Clin Lab Immunol; 1986 May; 20(1):1-6. PubMed ID: 3016274
[TBL] [Abstract][Full Text] [Related]
44. Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor.
Morgenthaler NG; Pampel I; Aust G; Seissler J; Scherbaum WA
Horm Metab Res; 1998 Mar; 30(3):162-8. PubMed ID: 9566861
[TBL] [Abstract][Full Text] [Related]
45. Detection of TSH-binding inhibitor immunoglobulins by using the triton-solubilized receptor from human thyroid membranes.
Iida Y; Konishi J; Kasagi K; Kuma K; Torizuka K
Endocrinol Jpn; 1982 Apr; 29(2):227-31. PubMed ID: 6127209
[TBL] [Abstract][Full Text] [Related]
46. The assay for thyroid stimulating immunoglobulins using cultured human thyroid cells.
Grant SJ; Luttrell BM; Hales IB
Clin Endocrinol (Oxf); 1985 Oct; 23(4):325-34. PubMed ID: 2866050
[TBL] [Abstract][Full Text] [Related]
47. Thyroidal response to an increase or decrease of endogenous TSH in patients with hyperthyroidism and its correlation with TSH binding inhibiting immunoglobulin.
Katakura M; Koizumi Y; Aizawa T; Takasu N; Yamada T; Yukimura Y; Nagata H
Clin Exp Pharmacol Physiol; 1986 May; 13(5):407-15. PubMed ID: 2874908
[TBL] [Abstract][Full Text] [Related]
48. Epitope heterogeneity of thyrotropin receptor-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors.
Grasso YZ; Kim MR; Faiman C; Kohn LD; Tahara K; Gupta MK
Thyroid; 1999 Jun; 9(6):531-7. PubMed ID: 10411114
[TBL] [Abstract][Full Text] [Related]
49. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD
J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
[TBL] [Abstract][Full Text] [Related]
50. [Thyroid stimulators other than TSH. Classification. Immunoglobulins of Basedow's disease: history, methodology, nomenclature].
Orgiazzi J; Madec AM
Ann Endocrinol (Paris); 1982 Dec; 43(6):509-19. PubMed ID: 6134492
[TBL] [Abstract][Full Text] [Related]
51. A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy.
Lytton SD; Ponto KA; Kanitz M; Matheis N; Kohn LD; Kahaly GJ
J Clin Endocrinol Metab; 2010 May; 95(5):2123-31. PubMed ID: 20237164
[TBL] [Abstract][Full Text] [Related]
52. Comparison of two different TSH-receptor antibody assays: A clinical practice study.
van Balkum M; Schreurs MWJ; Visser WE; Peeters RP; Dik WA
Heliyon; 2023 Dec; 9(12):e22468. PubMed ID: 38107298
[TBL] [Abstract][Full Text] [Related]
53. Blocking type anti-tSH receptor antibodies detected by radioreceptor assay in Graves' disease.
Tada H; Izumi Y; Watanabe Y; Takano T; Fukata S; Kuma K; Hidaka Y; Amino N
Endocr J; 2001 Dec; 48(6):703-10. PubMed ID: 11873870
[TBL] [Abstract][Full Text] [Related]
54. Distinction between autoimmune and non-autoimmune hyperthyroidism by determination of TSH-receptor antibodies in patients with the initial diagnosis of toxic multinodular goiter.
Wallaschofski H; Orda C; Georgi P; Miehle K; Paschke R
Horm Metab Res; 2001 Aug; 33(8):504-7. PubMed ID: 11544566
[TBL] [Abstract][Full Text] [Related]
55. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
[TBL] [Abstract][Full Text] [Related]
56. Prognostic value of thyroid stimulating antibodies and TSH-binding inhibiting immunoglobulins in the follow-up of Graves' disease.
Hörmann R; Saller B; Müller R; Mann K
Klin Wochenschr; 1985 Dec; 63(24):1247-52. PubMed ID: 2868149
[TBL] [Abstract][Full Text] [Related]
57. Clinical relevance of thyroid-stimulating immunoglobulins in graves' ophthalmopathy.
Ponto KA; Kanitz M; Olivo PD; Pitz S; Pfeiffer N; Kahaly GJ
Ophthalmology; 2011 Nov; 118(11):2279-85. PubMed ID: 21684605
[TBL] [Abstract][Full Text] [Related]
58. A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor.
Nagayama Y; Kita-Furuyama M; Ando T; Nakao K; Mizuguchi H; Hayakawa T; Eguchi K; Niwa M
J Immunol; 2002 Mar; 168(6):2789-94. PubMed ID: 11884447
[TBL] [Abstract][Full Text] [Related]
59. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.
Schott M; Minich WB; Willenberg HS; Papewalis C; Seissler J; Feldkamp J; Bergmann A; Scherbaum WA; Morgenthaler NG
Horm Metab Res; 2005 Dec; 37(12):741-4. PubMed ID: 16372227
[TBL] [Abstract][Full Text] [Related]
60. Graves' disease in pregnancy: TSH receptor binding inhibiting immunoglobulins and maternal and neonatal thyroid function.
Mortimer RH; Tyack SA; Galligan JP; Perry-Keene DA; Tan YM
Clin Endocrinol (Oxf); 1990 Feb; 32(2):141-52. PubMed ID: 1971773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
